Strides Arcolab's gets continued US FDA approval status for Bangalore facility
The oral dosage forms manufacturing plant supports important current and future submissions for the US market
Strides Arcolab has announced that its oral dosage forms manufacturing site (KRS Gardens) in Bangalore was recently inspected by the US FDA as part of GMP compliance audit and the facility continues to be approved.
The last US FDA inspection and approval for this facility was in the year 2011.
The KRS Gardens facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets. The manufacturing plant supports important current and future submissions for the US market.
The last US FDA inspection and approval for this facility was in the year 2011.
The KRS Gardens facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets. The manufacturing plant supports important current and future submissions for the US market.